Practical Matters: Rare Disease Advocates Want Help From US FDA Hub To Make Data Useful
US FDA’s Rare Disease Innovation Hub should shepherd the practical transformation of the diverse wealth of patient-generated data held by advocacy organizations into information for regulatory use, Reagan-Udall public meeting hears.
